Swedish Orphan Biovitrum AB, commonly known as Sobi, is a specialty biopharmaceutical company based in Sweden. It develops and supplies medicines for people with rare diseases, with a particular focus on haemophilia and other bleeding disorders, and it also provides treatments in immunology and inflammation. Its customers are mainly healthcare providers, hospitals and specialist clinics that care for patients with these uncommon conditions, and its products are used across European and other international markets.
On this site Swedish Orphan Biovitrum AB appears as a stock on the London Exchange (UK), code 0MTD, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
The first paragraph was written with AI from general knowledge about the company and checked automatically; the second comes from our own data. It can contain mistakes: check the company's own website and filings before relying on it.
Market X-Ray · price-based
Strong price profile
Ranks #466 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
65/100
Mixed trend against its averages.
See the numbers →
Above 200-day average3.5%
From 52-week high-9.8%
MomentumFair
60/100
Typical recent returns for this exchange.
See the numbers →
3-month return-6.4%
6-month return5.3%
12-month, skipping last month47.2%
Risk (lower is better)Strong
79/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility (1 year)26.0%
Worst drawdown (1 year)-15.6%
LiquidityStrong
84/100
Trades actively.
See the numbers →
Avg daily value traded46.62M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 305.20 – 486.40Daily closes, split-adjusted
Signals
50-day average445.84
200-day average420.96
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)9.54
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
431.9
Bullish
EMA 10
434.1
Bullish
SMA 20
435.0
Bullish
EMA 20
436.0
Bearish
SMA 50
445.8
Bearish
EMA 50
442.3
Bearish
SMA 100
450.6
Bearish
EMA 100
439.9
Bearish
SMA 200
421.0
Bullish
EMA 200
418.2
Bullish
Oscillators (daily)
RSI (14)
48.25
Neutral
MACD (12, 26)
-3.44
Bearish
Momentum (12)
-1.00
Bearish
Stochastic %K (14)
56.49
Neutral
Williams %R (14)
-43.51
Neutral
CCI (20)
48.49
Neutral
Pivot points (classic, last session)
S3
420.4
S2
428.0
S1
431.8
Pivot
439.4
R1
443.2
R2
450.8
R3
454.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.